Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Patheon to Manufacture Ferric Citrate for Keryx | Contract Pharma

What are you searching for?

Sign in
Breaking News

Patheon to Manufacture Ferric Citrate for Keryx

Auryxia is now available for prescription in the U.S.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon Manufacturing Services has partnered with Keryx Biopharmaceuticals to manufacture Auryxia (ferric citrate) in the U.S.

Keryx recently received approval from the U.S. Food and Drug Administration (FDA) for its application for a second drug product contract manufacturer for ferric citrate. Patheon Manufacturing Services of Greenville, NC, is now an FDA approved drug product manufacturer of Auryxia. With FDA approval of this manufacturer, the company said it has rebuilt supply and will make Auryxia available to wholesalers.

“We are pleased with today’s approval, as it expands our manufacturing capabilities and capacity,” said Greg Madison, president and chief executive officer, Keryx Biopharmaceuticals. “Getting a second drug product manufacturer approved was an important step to ensuring long-term supply of Auryxia is consistently available to patients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters